» Articles » PMID: 30842938

Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation

Overview
Journal Front Pediatr
Specialty Pediatrics
Date 2019 Mar 8
PMID 30842938
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cystic fibrosis (CF) is a relatively rare disease in Asians with various clinical characteristics, including CF-associated liver disease (CFLD), which is a common early non-pulmonary complication. This case report describes a Chinese CF patient harboring a homozygous nonsense mutation (c.1657C>T, p.R553X) who was failure to thrive and had intermittently diarrhea during the first year after birth. Liver function test of the patient showed the mildly and intermittently elevated alanine aminotransferase (ALT) levels ranging from 70 to 92 U/L and aspartate aminotransferase (AST) levels ranging from 80 to 90 U/L, which began at 8 months of age and lasted for 4 years without CF diagnosis. In addition, abdominal computed tomography (CT) revealed diffuse fatty infiltration of the liver at 4 years old and gradually developed hepatic cirrhosis. Subsequently, cirrhosis rapidly progressed with obvious splenomegaly and pancreatic insufficiency and the patient died of liver failure with coagulopathy by the age of 6 years old. Pediatricians should remain vigilant to avoid failure to diagnose CF, the occurrence of which may be underestimated, and pay greater attention to the patients with atypical clinical manifestations in Asian countries.

Citing Articles

[Detection of pathogenic gene mutations in thirteen cases of congenital bilateral absence of vas deferens infertility patients].

Tang Y, Zhang Y, Wu D, Lin Y, Lan F Beijing Da Xue Xue Bao Yi Xue Ban. 2024; 56(5):763-774.

PMID: 39397452 PMC: 11480543.


Genetic spectrum of Chinese children with cystic fibrosis: comprehensive data analysis from the main referral centre in China.

Shen Y, Tang X, Chen Q, Xu H, Liu H, Liu J J Med Genet. 2022; .

PMID: 35858753 PMC: 9985745. DOI: 10.1136/jmg-2022-108501.


Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease.

Zhou T, Kundu D, Robles-Linares J, Meadows V, Sato K, Baiocchi L Cells. 2021; 10(8).

PMID: 34440841 PMC: 8391272. DOI: 10.3390/cells10082072.


Pediatric lung transplantation in the largest lung transplantation center of China: embarking on a long road.

Yue B, Wu B, Zhang J, Xu H, Wei D, Hu C Sci Rep. 2020; 10(1):12471.

PMID: 32719472 PMC: 7385630. DOI: 10.1038/s41598-020-69340-0.


Characterization of clinical and genetic spectrum of Chinese patients with cystic fibrosis.

Liu K, Xu W, Xiao M, Zhao X, Bian C, Zhang Q Orphanet J Rare Dis. 2020; 15(1):150.

PMID: 32539862 PMC: 7294671. DOI: 10.1186/s13023-020-01393-w.

References
1.
Wagner J, Vassilakis A, Yee K, Li M, Hurlock G, Krouse M . Two novel mutations in a cystic fibrosis patient of Chinese origin. Hum Genet. 1999; 104(6):511-5. DOI: 10.1007/s004390050996. View

2.
Guilloud-Bataille M, De Crozes D, Rault G, Degioanni A, Feingold J . Cystic fibrosis mutations: report from the French Registry. The Clinical Centers of the CF. Hum Hered. 2000; 50(2):142-5. DOI: 10.1159/000022903. View

3.
Dawson K, Frossard P . The geographic distribution of cystic fibrosis mutations gives clues about population origins. Eur J Pediatr. 2000; 159(7):496-9. DOI: 10.1007/s004310051317. View

4.
Wu C, Shu S, Zielenski J, Chiang C, Tsui L . Novel cystic fibrosis mutation (2215insG) in two adolescent Taiwanese siblings. J Formos Med Assoc. 2000; 99(7):564-7. View

5.
Colombo C, Battezzati P, Crosignani A, Morabito A, Costantini D, Padoan R . Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome. Hepatology. 2002; 36(6):1374-82. DOI: 10.1053/jhep.2002.37136. View